vs
Side-by-side financial comparison of EVOLUTION PETROLEUM CORP (EPM) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
EVOLUTION PETROLEUM CORP is the larger business by last-quarter revenue ($20.7M vs $13.8M, roughly 1.5× Gossamer Bio, Inc.). EVOLUTION PETROLEUM CORP runs the higher net margin — 5.2% vs -342.3%, a 347.5% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 2.0%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
EPM vs GOSS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $13.8M |
| Net Profit | $1.1M | $-47.2M |
| Gross Margin | 44.3% | — |
| Operating Margin | 3.2% | -333.6% |
| Net Margin | 5.2% | -342.3% |
| Revenue YoY | 2.0% | 47.1% |
| Net Profit YoY | 158.4% | -43.0% |
| EPS (diluted) | $0.03 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | $13.8M | ||
| Q3 25 | $21.3M | $13.3M | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $22.6M | — | ||
| Q4 24 | $20.3M | — | ||
| Q3 24 | $21.9M | — | ||
| Q2 24 | $21.2M | $95.8M | ||
| Q1 24 | $23.0M | $0 |
| Q4 25 | $1.1M | $-47.2M | ||
| Q3 25 | $824.0K | $-48.2M | ||
| Q2 25 | $3.4M | — | ||
| Q1 25 | $-2.2M | — | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $1.2M | $49.2M | ||
| Q1 24 | $289.0K | $-41.9M |
| Q4 25 | 44.3% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 46.1% | — | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 46.2% | — | ||
| Q2 24 | 46.3% | — | ||
| Q1 24 | 45.2% | — |
| Q4 25 | 3.2% | -333.6% | ||
| Q3 25 | -0.4% | -369.4% | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | -3.0% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 11.3% | 54.3% | ||
| Q1 24 | 9.1% | — |
| Q4 25 | 5.2% | -342.3% | ||
| Q3 25 | 3.9% | -362.7% | ||
| Q2 25 | 16.2% | — | ||
| Q1 25 | -9.7% | — | ||
| Q4 24 | -9.0% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 5.8% | 51.4% | ||
| Q1 24 | 1.3% | — |
| Q4 25 | $0.03 | $-0.21 | ||
| Q3 25 | $0.02 | $-0.21 | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $0.06 | — | ||
| Q2 24 | $0.04 | $0.22 | ||
| Q1 24 | $0.01 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.8M | $136.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $67.5M | $-122.8M |
| Total Assets | $169.3M | $172.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $136.9M | ||
| Q3 25 | $714.0K | $180.2M | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $5.6M | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $6.9M | — | ||
| Q2 24 | $6.4M | $354.5M | ||
| Q1 24 | $3.1M | $244.4M |
| Q4 25 | $67.5M | $-122.8M | ||
| Q3 25 | $69.1M | $-82.3M | ||
| Q2 25 | $71.8M | — | ||
| Q1 25 | $71.7M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $79.6M | — | ||
| Q2 24 | $81.1M | $81.5M | ||
| Q1 24 | $83.5M | $26.7M |
| Q4 25 | $169.3M | $172.2M | ||
| Q3 25 | $169.1M | $208.8M | ||
| Q2 25 | $160.3M | — | ||
| Q1 25 | $156.4M | — | ||
| Q4 24 | $160.2M | — | ||
| Q3 24 | $157.9M | — | ||
| Q2 24 | $162.9M | $373.4M | ||
| Q1 24 | $166.5M | $259.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-48.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 5.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-48.3M | ||
| Q3 25 | $7.8M | $-36.2M | ||
| Q2 25 | $10.5M | — | ||
| Q1 25 | $7.3M | — | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $7.6M | — | ||
| Q2 24 | $8.0M | $116.3M | ||
| Q1 24 | $3.4M | $-52.3M |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — |
| Q4 25 | 5.09× | — | ||
| Q3 25 | 9.47× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.69× | — | ||
| Q2 24 | 6.47× | 2.36× | ||
| Q1 24 | 11.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |
GOSS
Segment breakdown not available.
